1. A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0·5 mg kg−1 daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial. (1st July 2015) Authors: Chalmers, J.R.; Wojnarowska, F.; Kirtschig, G.; Nunn, A.J.; Bratton, D.J.; Mason, J.; Foster, K.A.; Whitham, D.; Williams, H.C.; Williams, H.; Mason, J.; McDermott, M.; Yong, A.; Chriba, M.; Banks‐Dunnell, K.; Butcher, D.; Cox, N.; Nik, M.; Gilbanks, K.; Davies, K. Journal: British journal of dermatology Issue: Volume 173:Number 1(2015:Jul.) Page Start: 227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0·5 mg kg−1 daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial. (26th May 2015) Authors: Chalmers, J.R.; Wojnarowska, F.; Kirtschig, G.; Nunn, A.J.; Bratton, D.J.; Mason, J.; Foster, K.A.; Whitham, D.; Williams, H.C.; the BLISTER study group; Williams, H.; Mason, J.; McDermott, M.; Yong, A.; Chriba, M.; Banks‐Dunnell, K.; Butcher, D.; Cox, N.; Nik, M.; Gilbanks, K. Journal: British journal of dermatology Issue: Volume 173:Number 1(2015:Jul.) Page Start: 227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Anakinra for palmoplantar pustulosis: results from a randomized, double‐blind, multicentre, two‐staged, adaptive placebo‐controlled trial (APRICOT). (12th October 2021) Authors: Cro, S.; Cornelius, V.R.; Pink, A.E.; Wilson, R.; Pushpa‐Rajah, A.; Patel, P.; Abdul‐Wahab, A.; August, S.; Azad, J.; Becher, G.; Chapman, A.; Dunnill, G.; Ferguson, A.D.; Fogo, A.; Ghaffar, S.A.; Ingram, J.R.; Kavakleiva, S.; Ladoyanni, E.; Leman, J.A.; Macbeth, A.E. Other Names: Altamura Davide investigator.; Piguet Vincent investigator.; Verdolini Roberto investigator.; Wallace Marc investigator.; Sundararaj Kavitha investigator.; Arujuna Nisha investigator.; Fleming Charlotte investigator.; Lamb Ruth investigator.; Dodds Jacqueline investigator.; Baryschpolec Sonia inv... Journal: British journal of dermatology Issue: Volume 186:Number 2(2022) Page Start: 245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Anakinra for palmoplantar pustulosis: results from a randomized, double‐blind, multicentre, two‐staged, adaptive placebo‐controlled trial (APRICOT). (1st February 2022) Authors: Cro, S.; Cornelius, V.R.; Pink, A.E.; Wilson, R.; Pushpa‐Rajah, A.; Patel, P.; Abdul‐Wahab, A.; August, S.; Azad, J.; Becher, G.; Chapman, A.; Dunnill, G.; Ferguson, A.D.; Fogo, A.; Ghaffar, S.A.; Ingram, J.R.; Kavakleiva, S.; Ladoyanni, E.; Leman, J.A.; Macbeth, A.E. Journal: British journal of dermatology Issue: Volume 186:Number 2(2022) Page Start: 245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Prospective study in bullous pemphigoid: association of high serum anti‐BP180 IgG levels with increased mortality and reduced Karnofsky score. (1st October 2018) Authors: Holtsche, M.M.; Goletz, S.; van Beek, N.; Zillikens, D.; Benoit, S.; Harman, K.; Walton, S.; English, J.; Sticherling, M.; Chapman, A.; Levell, N.J.; Groves, R.; Williams, H.C.; König, I.R.; Schmidt, E.; Günther, C.; Luger, T.; Steinbrink, K.; Wozel, G.; Akhras, V. Journal: British journal of dermatology Issue: Volume 179:Number 4(2018) Page Start: 918 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The PROCLIPI international registry of early‐stage mycosis fungoides identifies substantial diagnostic delay in most patients. (1st August 2019) Authors: Scarisbrick, J.J.; Quaglino, P.; Prince, H.M.; Papadavid, E.; Hodak, E.; Bagot, M.; Servitje, O.; Berti, E.; Ortiz‐Romero, P.; Stadler, R.; Patsatsi, A.; Knobler, R.; Guenova, E.; Child, F.; Whittaker, S.; Nikolaou, V.; Tomasini, C.; Amitay, I.; Prag Naveh, H.; Ram‐Wolff, C. Journal: British journal of dermatology Issue: Volume 181:Number 2(2019) Page Start: 350 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The PROCLIPI international registry of early‐stage mycosis fungoides identifies substantial diagnostic delay in most patients. (25th November 2018) Authors: Scarisbrick, J.J.; Quaglino, P.; Prince, H.M.; Papadavid, E.; Hodak, E.; Bagot, M.; Servitje, O.; Berti, E.; Ortiz‐Romero, P.; Stadler, R.; Patsatsi, A.; Knobler, R.; Guenova, E.; Child, F.; Whittaker, S.; Nikolaou, V.; Tomasini, C.; Amitay, I.; Prag Naveh, H.; Ram‐Wolff, C. Journal: British journal of dermatology Issue: Volume 181:Number 2(2019) Page Start: 350 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. U.K. consensus statement on safe clinical prescribing of bexarotene for patients with cutaneous T‐cell lymphoma. (3rd December 2012) Authors: Scarisbrick, J.J.; Morris, S.; Azurdia, R.; Illidge, T.; Parry, E.; Graham‐Brown, R.; Cowan, R.; Gallop‐Evans, E.; Wachsmuth, R.; Eagle, M.; Wierzbicki, A.S.; Soran, H.; Whittaker, S.; Wain, E.M. Journal: British journal of dermatology Issue: Volume 168:Number 1(2013:Jan.) Page Start: 192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗